Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-Squamous Non-Small Cell Lung Cancer × lifastuzumab vedotin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-Squamous Non-Small Cell Lung Cancer 1

Interventions

Cisplatin 4 Bevacizumab 4 Carboplatin 3 Paclitaxel 2 lifastuzumab vedotin 1 imgatuzumab 1 Vinorelbine 1 Pemetrexed 1 Gemcitabine 1 Etoposide 1 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01995188 2017-10-04

A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

Genentech, Inc.

Phase 1 Completed

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡